Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-MSC conditioned medium for chronic knee osteoarthritis pain
jRCT1051260011Active, not recruiting
- Sponsor
- Sugawara Orthopedic Clinic
- Start
- Apr 2026
- Modality
- Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human adipose-derived mesenchymal stem cell conditioned medium in knee osteoarthritis (OA), sponsored by Sugawara Orthopedic Clinic. Primary endpoints: Safety assessment and Analgesic effect (NRS and KOOS). Started Apr 2026; status: active, not recruiting.
02
Drugs
human adipose-derived mesenchymal stem cell conditioned medium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT1051260011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260011.